Carenostics ^Companies

Carenostics is an organization that focuses on addressing the underdiagnosis, undertreatment, and health inequities of chronic diseases using AI and ML technologies. They have developed healthcare AI products that have received FDA and PMA approval. With their innovative approach, they have been able to deploy their solutions in healthcare systems nationwide, with over 1,000 deployments globally. Carenostics has also received recognition for their work, including being awarded the 2023 Innovative Practices Award by Bio-IT World and being the only investment of 2022 by Bayer G4A. They have also partnered with Hackensack Meridian Health to revolutionize the care for chronic kidney disease.